| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/06/2001 | CN1066624C Dry mix formulation for bisphosphonic acids |
| 06/05/2001 | US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present |
| 06/05/2001 | US6242566 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/05/2001 | US6242497 Use of 6,7-substituted 2-aminotetralines suitable for preparing a pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 06/05/2001 | US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation |
| 06/05/2001 | US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 06/05/2001 | US6242434 Treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders. |
| 06/05/2001 | US6242419 Genes encoding proteins expressed in lymph node stromal cells from flaky skin (fsn-/-) mice and their use in therapy. |
| 06/05/2001 | US6242415 Mediation of cytokines by melanin |
| 06/05/2001 | US6242249 Nucleotide sequences of trigger factor chaperones from staphylococcus; diagnosis; probes; primers; vaccines; bactericides; bacteriostats; antibodies; drug screening |
| 06/05/2001 | US6242212 Nucleotide sequences which code a protein for the diagnosis, detection and treatment of cancer |
| 06/03/2001 | CA2327385A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/03/2001 | CA2327256A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 05/31/2001 | WO2001038878A2 Pin1 as a marker for abnormal cell growth |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038397A1 N-alkylated peptides having antiangiogenic activity |
| 05/31/2001 | WO2001038393A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 05/31/2001 | WO2001038392A1 Novel transcription factor and dna thereof |
| 05/31/2001 | WO2001038355A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
| 05/31/2001 | WO2001038347A2 Peptides having antiangiogenic activity |
| 05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | WO2001038323A1 Pyrazinone thrombin inhibitors |
| 05/31/2001 | WO2001038320A1 Vitamin d analogues |
| 05/31/2001 | WO2001038314A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 05/31/2001 | WO2001038313A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p39 kINASE INHIBITORS |
| 05/31/2001 | WO2001038312A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001038311A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | WO2001038305A2 Novel il-8 receptor antagonists |
| 05/31/2001 | WO2001038303A2 Vitamin d analogues |
| 05/31/2001 | WO2001037877A1 Remedies for diseases in association with decrease in bone mass |
| 05/31/2001 | WO2001037870A1 Treatment of autoimmune diseases by an agonistic cd40-binding protein |
| 05/31/2001 | WO2001037868A1 Assays and therapies for latent viral infection |
| 05/31/2001 | WO2001037861A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037841A1 Pharmaceutical compositions comprising trimegestone |
| 05/31/2001 | WO2001037837A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001037823A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 05/31/2001 | WO2001037820A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 05/31/2001 | WO2001037808A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | WO2001005411A8 Compositions addressing inflammation and/or degenerative disorders |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | WO2000071140A3 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 05/31/2001 | WO2000069472A3 Enzyme-activated anti-tumor prodrug compounds |
| 05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
| 05/31/2001 | WO2000056350A3 Methods of use of beta 1-integrin inhibitors |
| 05/31/2001 | WO2000047194A9 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 05/31/2001 | WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response |
| 05/31/2001 | WO2000009512A3 Bipyridine manganese complexes |
| 05/31/2001 | US20010002401 Establishing the status of the mammal as presently or prospectively being in early stages of degeneration of articular cartilage or subchondral bone in one or more joinsts, administering a xanthine chondroprotective compound |
| 05/31/2001 | US20010002398 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98% |
| 05/31/2001 | US20010002397 24-Hydroxyvitamin D, analogs and uses thereof |
| 05/31/2001 | CA2706113A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | CA2395049A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | CA2392456A1 Assays and therapies for latent viral infection |
| 05/31/2001 | CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2392351A1 Novel transcription factor and dna thereof |
| 05/31/2001 | CA2392225A1 Novel il-8 receptor antagonists |
| 05/31/2001 | CA2392175A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance |
| 05/31/2001 | CA2392019A1 Method of forming a peptide-receptor complex with zsig33 |
| 05/31/2001 | CA2391526A1 A pharmaceutical composition for treatment of diseases associated with decrease in bone mass |
| 05/31/2001 | CA2391386A1 Peptides having antiangiogenic activity |
| 05/31/2001 | CA2391012A1 Pyrazinone thrombin inhibitors |
| 05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | CA2386893A1 N-alkylated peptides having antiangiogenic activity |
| 05/30/2001 | EP1103553A2 Substituted heterocyclic derivatives |
| 05/30/2001 | EP1103552A1 Benzothiepin derivatives, process for the preparation of the same and uses thereof |
| 05/30/2001 | EP1103272A2 Modulation of TGF-beta by proteolytic enzymes |
| 05/30/2001 | EP1102862A1 Antisense oligonucleotides targeted to il-15 |
| 05/30/2001 | EP1102755A1 Substituted isoxazole derivatives as estrogen receptor modulators |
| 05/30/2001 | EP1102753A2 Pyrazoles as estrogen receptor modulators |
| 05/30/2001 | EP1102750A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 05/30/2001 | EP1102746A1 Substituted phenylamidines with antithrombotic action |
| 05/30/2001 | EP1102743A1 Amide derivatives which are useful as cytokine inhibitors |
| 05/30/2001 | EP1102590A1 Use of a nk-1 receptor antagonist for treating or preventing abnormal bone resorption |
| 05/30/2001 | EP1102587A2 Vitronectin receptor antagonists |
| 05/30/2001 | EP1102535A2 Compounds and methods |
| 05/30/2001 | EP0730607B1 Novel integrin-binding peptides |
| 05/30/2001 | CN1297436A Substd. pyrrolidine hydroxamate metalloprotease inhibitors |
| 05/30/2001 | CN1296849A Medicine for dispersing stasis and conditioning tendon |
| 05/30/2001 | CN1296846A Zhiqi plaster and its preparing process |
| 05/30/2001 | CN1296844A Chinese medicine for treating femur head necrosis |
| 05/30/2001 | CN1296838A Medicine for treating hyperosteogeny |
| 05/30/2001 | CN1296827A Quick-acting bone-setting powder medicine |
| 05/30/2001 | CN1296804A Process for preparing recombined heterobone with strong anti-infection power |
| 05/30/2001 | CN1066337C Drug for curing rheumatic arthritis and rheumatoid arthritis |
| 05/30/2001 | CN1066334C Medicines for treating bone tuberculosis, osteomyelitis and other swelling pain |
| 05/30/2001 | CN1066333C Traditional Chinese drug for quick radically curing osteomyelitis |
| 05/29/2001 | US6239288 Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis |
| 05/29/2001 | US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents |
| 05/29/2001 | US6239151 Compounds as inhibitor of tumor necrosis factor alpha release |
| 05/29/2001 | US6239148 Treatment of painful, hyperalgesic and/or inflammatory conditions in which c-fibers play a role by eliciting neurogenic pain, insulin resistance in diabetes mellitus or aging, inhibit insulin antagonizing peptide, |
| 05/29/2001 | US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring |
| 05/29/2001 | US6239138 Vitronectin receptor antagonist |
| 05/29/2001 | US6239137 Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activity |
| 05/29/2001 | US6239130 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 05/29/2001 | US6239121 4- Halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same |
| 05/29/2001 | US6239116 Immunostimulatory nucleic acid molecules |
| 05/29/2001 | US6239102 Concentrate comprising, as active agent, (3'-desoxy-3-oxo-mebmc)1-(val)2-cyclosporin, stabilizer selected from oleic acid or palmitoyl oleoyl phosphatidyl glycerol or salts thereof, ethanol |
| 05/29/2001 | US6238914 Nucleic acid |
| 05/29/2001 | US6238900 Nucleotide sequence coding enzymatic polypeptide; for the prevention of bacterial infections; bactericides |